Type
. Leprosy at the cutting edge: 2000 to 2005, and beyond. Tropical doctor. 2002;32(1):46-8.
Type
. DNA-PCR and RT-PCR for the 18-kDa gene of Mycobacterium leprae to assess the efficacy of multi-drug therapy for leprosy. Journal of medical microbiology. 2002;51(5):417-22.
Type
. Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells. Science (New York, N.Y.). 2002;296(5569):927-31.
Type
. Microbiology. Subversion of Schwann cells and the leper's bell. Science (New York, N.Y.). 2002;296(5569):862-3.
Type
. Patients teach spirit of nursing. Reflections on nursing leadership. 2000;26(2):37.
Type
. High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy. Clinical and experimental immunology [Internet]. 2002;128(2):333-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906406/pdf/cei0128-0333.pdf
Type
. Chronic ulcers and myasis as ports of entry for Clostridium tetani. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2001;5(6):319-23.
Type
. [Susceptibility to Mycobacterium leprae of congenic hypertensive nude rat (SHR/NCrj-rnu) and production of cytokine from the resident peritoneal macrophages]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2002;71(1):39-45.
Type
. [Leprosy reactions]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2002;71(1):3-29.
Type
. [The diseases ŷudām and baras (leprosy) in treatises of Islamic Law (Malikí Doctrine)]. Dynamis (Granada, Spain). 2001;21:55-71.